CLINICAL ROLE -
Call to Action: Investigation of Metformin as Adjunctive Therapy to Immunotherapies in Non-Small Cell Lung Cancer
Metformin has been shown to decrease pro-inflammatory cytokines that appear to improve the immune response to tumor cells and improve the efficacy of immunotherapy.
Read More